Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder / Michael S. Ritsner en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 10 (Octubre)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 10 (Octubre) . - pp. 1351-1362 Título : Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder : an 8 week, double blind, randomized, controlled, 2 center, parallel group trial Tipo de documento: texto impreso Autores: Michael S. Ritsner, Autor ; Anatoly Gibel, Autor ; Tatyana Shleifer, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1351-1362 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Dehidroepiandrosterona, Farmacoterapia, combinación, Discinesia inducida por fármacos, Memoria a corto plazo, Neurotransmisores, Pregnenolona, Trastornos psicóticos, Esquizofrenia, Índice de gravedad de la enfermedad. Resumen: Pregnenolone (PREG) and dehydroepiandrosterone (DHEA) are reported to have a modulatory effect on neuronal excitability, synaptic plasticity, and response to stress; they are associated with mood regulation and cognitive performance. We investigated the influence of PREG and DHEA on psychotic symptoms and cognitive functioning as an add-on to ongoing antipsychotic treatment of patients with chronic schizophrenia or schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=28247 [artículo] Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder : an 8 week, double blind, randomized, controlled, 2 center, parallel group trial [texto impreso] / Michael S. Ritsner, Autor ; Anatoly Gibel, Autor ; Tatyana Shleifer, Autor . - 2022 . - pp. 1351-1362. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 10 (Octubre) . - pp. 1351-1362 Palabras clave: Antipsicóticos, Dehidroepiandrosterona, Farmacoterapia, combinación, Discinesia inducida por fármacos, Memoria a corto plazo, Neurotransmisores, Pregnenolona, Trastornos psicóticos, Esquizofrenia, Índice de gravedad de la enfermedad. Resumen: Pregnenolone (PREG) and dehydroepiandrosterone (DHEA) are reported to have a modulatory effect on neuronal excitability, synaptic plasticity, and response to stress; they are associated with mood regulation and cognitive performance. We investigated the influence of PREG and DHEA on psychotic symptoms and cognitive functioning as an add-on to ongoing antipsychotic treatment of patients with chronic schizophrenia or schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=28247

Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice / Michael S. Ritsner en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 6 (Diciembre) . - PP. 582-591 Título : Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice : A naturalistic comparative study Tipo de documento: texto impreso Autores: Michael S. Ritsner, Autor ; Anatoly Gibel, Autor ; Galina Perelroyzen, Autor Fecha de publicación: 2023 Artículo en la página: PP. 582-591 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Atención Ambulatoria, Antipsicóticos, Benzodiacepinas, Calidad de Vida, Risperidona, Esquizofrenia, Psicología esquizofrénica. Resumen: Findings in previous studies investigating the beneficial effect of risperidone and olanzapine versus typical antipsychotics on quality of life (QOL) are controversial since they did not adjust for various factors contributing to QOL. To test this assumption in a naturalistic cross-sectional design, we evaluated general and domain-specific QOL scores for baseline data of schizophrenia outpatients stabilized on atypical (N = 78, risperidone or olanzapine) and typical (N = 55) agents. Link: ./index.php?lvl=notice_display&id=30929 [artículo] Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice : A naturalistic comparative study [texto impreso] / Michael S. Ritsner, Autor ; Anatoly Gibel, Autor ; Galina Perelroyzen, Autor . - 2023 . - PP. 582-591. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 6 (Diciembre) . - PP. 582-591 Palabras clave: Atención Ambulatoria, Antipsicóticos, Benzodiacepinas, Calidad de Vida, Risperidona, Esquizofrenia, Psicología esquizofrénica. Resumen: Findings in previous studies investigating the beneficial effect of risperidone and olanzapine versus typical antipsychotics on quality of life (QOL) are controversial since they did not adjust for various factors contributing to QOL. To test this assumption in a naturalistic cross-sectional design, we evaluated general and domain-specific QOL scores for baseline data of schizophrenia outpatients stabilized on atypical (N = 78, risperidone or olanzapine) and typical (N = 55) agents. Link: ./index.php?lvl=notice_display&id=30929

L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder / Michael S. Ritsner en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No.1 (Enero)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.1 (Enero) . - pp. 34-42 Título : L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder : an 8-week, randomized, double-blind, placebo-controlled, 2-center study Tipo de documento: texto impreso Autores: Michael S. Ritsner, Autor ; Chanoch Miodownik, Autor ; Yael Ratner, Autor Fecha de publicación: 2022 Artículo en la página: pp. 34-42 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos cognitivos, Terapia farmacológica, Glutamatos, Pruebas neuropsicológicas, Trastornos psicóticos, Esquizofrenia. Resumen: L-theanine is a unique amino acid present almost exclusively in the tea plant. It possesses neuroprotective, mood-enhancing, and relaxation properties. This is a first study designed to evaluate the efficacy and tolerability of L-theanine augmentation of antipsychotic treatment of patients with chronic schizophrenia and schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=27924 [artículo] L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder : an 8-week, randomized, double-blind, placebo-controlled, 2-center study [texto impreso] / Michael S. Ritsner, Autor ; Chanoch Miodownik, Autor ; Yael Ratner, Autor . - 2022 . - pp. 34-42. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.1 (Enero) . - pp. 34-42 Palabras clave: Trastornos cognitivos, Terapia farmacológica, Glutamatos, Pruebas neuropsicológicas, Trastornos psicóticos, Esquizofrenia. Resumen: L-theanine is a unique amino acid present almost exclusively in the tea plant. It possesses neuroprotective, mood-enhancing, and relaxation properties. This is a first study designed to evaluate the efficacy and tolerability of L-theanine augmentation of antipsychotic treatment of patients with chronic schizophrenia and schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=27924

---

1 (1 - 3 / 3)